DXYN

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 62.99 M68.57 M62.38 M63.49 M59.38 M 253.82 M Gross profit 16.9 M20.02 M15.48 M17.15 M19.29 M 71.94 M Operating expenses 17.06 M16.96 M16.44 M18.39 M16.29 M 68.08 M Selling/general/admin expenses 16.87 M16.78 M16.36 M17.66 M16 M 66.8 M Research & development ————— — Operating income 11 K3.19 M-2.02 M-1.06 M3.26 M 3.37 M Non-Operating Income, Total -132 K-12 K-51 K43 K21 K 1 000 Interest expense, net of interest capitalized 1.49 M1.87 M2.01 M1.93 M1.91 M 7.72 M Non-Operating Income, excl. Interest Expenses -1.54 M-1.89 M-2.08 M-1.95 M-1.92 M -7.83 M Unusual income/expense -88 K4 00016 K57 K32 K 109 K Pretax income -1.57 M1.32 M-4.02 M-2.93 M1.39 M -4.24 M Equity in earnings ————— — Taxes 12 K67 K-23 K17 K37 K 98 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -1.58 M1.25 M-4 M-2.95 M1.35 M -4.34 M Discontinued operations -115 K-94 K-79 K-52 K-203 K -428 K Net income -1.7 M1.16 M-4.08 M-3 M1.15 M -4.77 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -1.7 M1.1 M-4.08 M-2.94 M1.09 M -4.83 M Basic earnings per share (Basic EPS) -0.120.07-0.29-0.180.08 -0.32 Diluted earnings per share (Diluted EPS) -0.120.07-0.29-0.180.08 -0.32 Average basic shares outstanding 14.37 M14.5 M14.53 M14.48 M14.53 M — Diluted shares outstanding 14.37 M14.59 M14.53 M14.48 M14.63 M — EBITDA 1.19 M4.49 M458 K182 K4.36 M 9.49 M EBIT -161 K3.06 M-963 K-1.23 M3 M 3.86 M Cost of revenue 46.09 M48.56 M46.9 M46.34 M40.09 M 181.88 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.35 M1.43 M1.42 M1.42 M1.36 M 5.63 M